New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
05:41 EDTAMAGAMAG Pharmaceuticals upgraded to Hold from Underperform at Jefferies
Jefferies upgraded AMAG Pharmaceuticals to Hold citing limited downside potential after the FDA issued a complete response letter for Feraheme broader use. The firm raised its price target for shares to $19 from $16.
News For AMAG From The Last 14 Days
Check below for free stories on AMAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AMAG

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use